Talbot Financial’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$44.5M Buy
37,106
+1,092
+3% +$1.12M 3.28% 8
2026
Q1
$33.1M Buy
36,014
+324
+0.9% +$328K 2.78% 9
2025
Q4
$38.4M Sell
35,690
-644
-2% -$616K 3.16% 8
2025
Q3
$27.7M Buy
36,334
+9,247
+34% +$6.88M 2.35% 10
2025
Q2
$21.1M Buy
27,087
+6,071
+29% +$4.72M 2% 15
2025
Q1
$17.4M Sell
21,016
-260
-1% -$216K 2.17% 12
2024
Q4
$16.4M Buy
21,276
+4,199
+25% +$3.48M 1.95% 15
2024
Q3
$15.1M Buy
17,077
+789
+5% +$709K 1.84% 20
2024
Q2
$14.7M Buy
16,288
+362
+2% +$290K 1.9% 15
2024
Q1
$12.4M Buy
15,926
+262
+2% +$186K 1.66% 21
2023
Q4
$9.13M Buy
15,664
+526
+3% +$307K 1.37% 29
2023
Q3
$8.13M Buy
15,138
+370
+3% +$191K 1.42% 29
2023
Q2
$6.93M Buy
14,768
+78
+0.5% +$32.7K 1.18% 36
2023
Q1
$5.04M Buy
+14,690
New +$4.95M 0.94% 41

Other funds holding LLY

Talbot Financial's LLY Position: Q2 2026 in Review

Talbot Financial increased its Eli Lilly (LLY) stake by 3% in Q2 2026, buying an estimated $1.12M and bringing the position to 37,106 shares worth $44.5M. The position accounts for 3.28% of the portfolio, ranked #8.

Talbot Financial first reported a position in LLY in Q1 2023 and has held it in 14 quarters since. 841 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Talbot Financial held 37,106 shares of Eli Lilly worth $44.5M as of Q2 2026.
  • Talbot Financial bought 1,092 Eli Lilly shares in Q2 2026, an estimated $1.12M.
  • Eli Lilly made up 3.28% of Talbot Financial's portfolio in Q2 2026, its #8 holding.
  • Talbot Financial first reported a position in Eli Lilly in Q1 2023 and has held it in 14 quarters since.
  • 841 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Talbot Financial's 13F filing for Q2 2026, filed 14 Jul 2026.